RadNets Stock Surges on Strong Q3 Earnings and GE Healthcare Collaboration
| RDNT Stock | USD 55.42 1.26 2.22% |
Slightly above 61% of RadNet's investor base is looking to short. The analysis of overall sentiment of trading RadNet Inc stock suggests that many investors are alarmed at this time. RadNet's investing sentiment can be driven by a variety of factors including economic data, RadNet's earnings reports, geopolitical events, and overall market trends.
RadNet shares soared by 21 percent as the diagnostic imaging company reached a new all-time high following its Q3 report. The company posted a 38.5 percent year-over-y
Read at gurufocus.com
 |
RadNet Fundamental Analysis
We analyze RadNet's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RadNet using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RadNet based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
RadNet is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
RadNet Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with RadNet stock to make a market-neutral strategy. Peer analysis of RadNet could also be used in its relative valuation, which is a method of valuing RadNet by comparing valuation metrics with similar companies.
Peers
RadNet Related Equities
| ACRS | Aclaris Therapeutics | 18.90 | ||||
| MYGN | Myriad Genetics | 4.10 | ||||
| BDSX | Biodesix | 1.91 | ||||
| QGEN | Qiagen NV | 1.09 | ||||
| FONR | Fonar | 0.84 | ||||
| BIAFW | BioAffinity Technologies | 0.38 | ||||
| SERA | Sera Prognostics | 0.60 | ||||
| SHC | Sotera Health | 1.13 | ||||
| NEOG | Neogen | 2.11 | ||||
| XGN | Exagen | 2.94 | ||||
| BNR | Burning Rock | 3.95 |
Additional Tools for RadNet Stock Analysis
When running RadNet's price analysis, check to measure RadNet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RadNet is operating at the current time. Most of RadNet's value examination focuses on studying past and present price action to predict the probability of RadNet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RadNet's price. Additionally, you may evaluate how the addition of RadNet to your portfolios can decrease your overall portfolio volatility.